Argent Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
JC
WCG
FWCM
BRCM
IWA
NRS
WPC
GI
FFA
PCA
Argent Capital Management's EW Position: Q3 2026 in Review
Argent Capital Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 14,080 shares worth $1.22M. The position accounts for 0.04% of the portfolio, ranked #116.
Argent Capital Management first reported a position in EW in Q1 2020 and has held it in 27 quarters since. The position peaked at $2.1M in Q4 2021. 50 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Argent Capital Management held 14,080 shares of Edwards Lifesciences worth $1.22M as of Q3 2026.
- Argent Capital Management left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up 0.04% of Argent Capital Management's portfolio in Q3 2026, its #116 holding.
- Argent Capital Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 27 quarters since.
- Argent Capital Management's Edwards Lifesciences position peaked at $2.1M in Q4 2021.
- 50 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Argent Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.